KENYATTA WILSON: Open Payments
NPI 1457633034 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 19 payments from 11 companies in 2025. Trend: 2023 $347 · 2024 $399 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $117 |
| ABBVIE INC. | 3 | $73 |
| Exact Sciences Corporation | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Lilly USA, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Wegovy, VRAYLAR, The Cologuard Plus Collection Kit, CAPLYTA, MOUNJARO, TRELEGY ELLIPTA, UBRELVY, ACCRUFER.
Industry payments across MS — which companies pay providers there.
